Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
06/14/2012 | US20120148599 Methods and compositions for neural disease immunotherapy |
06/14/2012 | US20120148597 Human monoclonal antibodies to ctla-4 |
06/14/2012 | US20120148594 Mimotopes of hiv and uses thereof |
06/14/2012 | US20120148592 Neutralizing anti-ccl20 antibodies |
06/14/2012 | US20120148590 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
06/14/2012 | US20120148585 Fusion molecules and methods for treatment of immune diseases |
06/14/2012 | US20120148582 Engineered anti-il-23r antibodies |
06/14/2012 | US20120148580 Methods for identification of sites for igg conjugation |
06/14/2012 | US20120148578 Methods and compositions for inhibiting cd32b expressing cells |
06/14/2012 | US20120148572 Novel antibodies |
06/14/2012 | US20120148571 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and uses thereof |
06/14/2012 | US20120148567 Particulate hyaluronic acid formulations for cellular delivery of bioactive agents |
06/14/2012 | US20120148564 Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activity |
06/14/2012 | US20120148561 Use of runx3 and mir-532-5p as cancer markers and therapeutic targets |
06/14/2012 | US20120148559 Compositions and method for deimmunization of proteins |
06/14/2012 | US20120148555 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
06/14/2012 | US20120148553 Methods of generating natural killer cells |
06/14/2012 | US20120148552 Method and compositions for enhanced anti-tumor effector functioning of t cells |
06/14/2012 | US20120148551 Marrow stem cell and pancreatic beta cell fusion cell useful for the treatment of diabetes |
06/14/2012 | US20120148550 Methods, systems, and compositions for neuronal differentiation of multipotent stromal cells |
06/14/2012 | US20120148549 Method to isolate, identify, and use embryonic stem cells directed to forebrain interneuron fate |
06/14/2012 | US20120148548 Joint Repair Using Mesenchymal Stem Cells |
06/14/2012 | US20120148546 Pericyte progenitor cells and methods of generating and using same |
06/14/2012 | US20120148545 Cardiac muscle repair or regeneration using bone marrow-derived stem cells |
06/14/2012 | US20120148544 Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro |
06/14/2012 | US20120148543 Synthetic graft |
06/14/2012 | US20120148540 Proliferated cell lines and uses thereof |
06/14/2012 | US20120148539 Methods and Compositions for Tissue Engineering |
06/14/2012 | US20120148538 Composition for hard tissue formation and, dentin or pulp regeneration containing ameloblast, apical bud cell or its culture fluid as an active ingredient |
06/14/2012 | US20120148537 Methods to enhance cell migration and engraftment |
06/14/2012 | US20120148536 Methods and storage and retrieval of functional mature retinal cells |
06/14/2012 | US20120148530 Method for the treatment or prevention of virus infection using polybiguanide-based compounds |
06/14/2012 | US20120148529 Use of Inclusion Bodies as Therapeutic Agents |
06/14/2012 | US20120148527 TNF Superfamily Fusion Proteins |
06/14/2012 | US20120148500 Use of a Fluorinated Polymer as a Contrast Agent in Solid State 19F Magnetic Resonance Imaging (MRI), Scaffold Comprising Said Polymer and Use Thereof |
06/14/2012 | US20120148495 Methods for treating nicotinic acetylcholine receptor associated diseases |
06/14/2012 | US20120148490 Anti-ngf compositions and use thereof |
06/14/2012 | US20120145626 Device for renal cell expansion |
06/14/2012 | US20120145544 Novel ubiquitin ligase and use thereof |
06/14/2012 | CA2820681A1 Use of chimeric antigen receptor-modified t cells to treat cancer |
06/14/2012 | CA2820642A1 Galectin-9-secreting cell, and production method and use of the same |
06/14/2012 | CA2820419A1 Agents and methods for inhibiting human pluripotent stem cell growth |
06/14/2012 | CA2820395A1 Sub-totipotent stem cell product and epigenetic modification label thereof |
06/14/2012 | CA2820134A1 Human monoclonal antibody |
06/14/2012 | CA2819675A1 Methods of small molecule directed regeneration from pluripotent stem cells |
06/14/2012 | CA2817874A1 Feed mixing device and its use |
06/14/2012 | CA2815933A1 Efficient and effective supplement screening for the development of chemically defined media in cell culture |
06/13/2012 | EP2463653A1 Technique for classifying cells, image processing program and image processing device using the technique, and method for producing cell mass |
06/13/2012 | EP2463367A1 Novel ubiquitin ligase and use thereof |
06/13/2012 | EP2463361A1 Methods to derive stem cells and to induce the proliferation of a single isolated blastomere |
06/13/2012 | EP2463360A1 Methods for cell culture using a synthetic defined collagen mimetic surface |
06/13/2012 | EP2463301A1 Synthetic, defined fibronectin mimetic peptides and surfaces modified with the same |
06/13/2012 | EP2462936A1 SiRNA mediated post-transriptional gene-silencing of genes involved in alopecia |
06/13/2012 | EP2462230A2 Methods and compositions for targeted gene modification |
06/13/2012 | EP2462225A1 Method of efficiently establishing induced pluripotent stem cells |
06/13/2012 | EP2462222A1 Improved plants, microbes, and organisms |
06/13/2012 | EP2462163A1 Beta cell marker antibody |
06/13/2012 | EP2461833A1 Vaccine composition comprising 5'-cap modified rna |
06/13/2012 | EP2407479A9 Self-assembling peptide and peptide gel with high strength |
06/13/2012 | EP2129774B1 Cells for heart treatment |
06/13/2012 | EP2032690B1 Method for the in vitro preparation of living cells and/or cell accumulations from tissue |
06/13/2012 | EP2019858B1 Differentiation of multi-lineage progenitor cells to respiratory epithelial cells |
06/13/2012 | EP1869166B1 In vitro production of a cell population using feeder cells |
06/13/2012 | EP1702058B1 Methods and devices for microencapsulation of cells |
06/13/2012 | EP1597382B1 Genetically modified non-human mammals and cells |
06/13/2012 | EP1495053B1 Angiopoietin-2 and angiopoietin-1 specific binding agents |
06/13/2012 | EP1494697B1 Monomeric and dimeric fluorescent protein variants and methods for making same |
06/13/2012 | EP1490110B1 Anti-alpha v beta 6 antibodies |
06/13/2012 | EP1478761B1 Degradation of hydrophobic ester pesticides and toxins |
06/13/2012 | EP1442057B1 Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy |
06/13/2012 | EP1414471B1 Therapeutic agents comprising pro-apoptotic proteins |
06/13/2012 | EP1409646B1 Transgenic animals comprising a humanized immune system |
06/13/2012 | EP1379535B1 Expression vectors able to elicit improved immune response and methods of using same |
06/13/2012 | EP1297017B1 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
06/13/2012 | EP0904288B1 Vaccine comprising the pathogenic escherichia coli associated protein espa |
06/13/2012 | EP0451216B2 Humanized immunoglobulins and their production and use |
06/13/2012 | CN1950501B AMP deaminase originating in streptomyces and utilization thereof |
06/13/2012 | CN1930301B Methods for identifying proteins with starch phosphorylating enzymatic activity |
06/13/2012 | CN1835976B Aglycosyl anti- CD154 (CD 40 ligand) antibodies and uses thereof |
06/13/2012 | CN1606567B Antimicrobial polypeptides from pseudoplectania nigrella |
06/13/2012 | CN102498208A Gene capable of regulating number of primary panicle branches and use thereof |
06/13/2012 | CN102498206A Production of proteins in glutamine-free cell culture media |
06/13/2012 | CN102498205A Method for isolation of dermal stem cell |
06/13/2012 | CN102492710A Beta-glucosidase Cel1b, expression gene and application thereof |
06/13/2012 | CN102492704A Peanut AhFatA protein, coding gene and application thereof |
06/13/2012 | CN102492700A DNA sequence for coding delta15 fatty acid desaturase (FAD) of Myrmecia incisa and application thereof |
06/13/2012 | CN102492694A Brassica oleracea TT2 (transparent testa 2) gene and its application |
06/13/2012 | CN102492688A Soybean pod borer 18srDNA gene and its application |
06/13/2012 | CN102492658A PSer86 monoclonal antibody of Tip60, as well as preparation method and application of pSer86 monoclonal antibody |
06/13/2012 | CN102492657A Drug screening cell model using NF-kappa B as target and building and applications thereof |
06/13/2012 | CN102492656A High-flux anti-tumor drug screening cell model based on STAT3 and NF-kB two-signal channel serving as target, as well as building and application of high-flux anti-tumor drug screening cell model |
06/13/2012 | CN102492655A Preparation and identification method of human leukemia cell cytoplast |
06/13/2012 | CN102492654A Kit for separating human umbilical cord blood stem cells and its using method |
06/13/2012 | CN102492653A Method for inducing and differentiating mature fat cell from adult rabbit into cardiomyocyte |
06/13/2012 | CN102492652A Method for producing human stem cell by using egg |
06/13/2012 | CN102492651A Method for differentiating human amniotic epithelial cell into insulin secreting cell by virtue of in-vitro induction |
06/13/2012 | CN102492650A Construction method for Hexagrammos otakii cell line |
06/13/2012 | CN102492649A Agaricus bisporus protoplast and preparation method thereof |
06/13/2012 | CN102492648A Preparation method of porous chitosan scaffold |
06/13/2012 | CN102492039A Fully humanized antihuman HER2 monoclonal antibody |